Identification and validation of diagnostic and prognostic biomarkers in prostate cancer based on WGCNA
In summary, our study identified six hub genes, namely SLC14A1, COL4A6, MYOF, FLRT3, KRT15, and LAMB3, which can be utilized to establish a diagnostic model for PCa. The discovery may offer potential molecular targets for clinical diagnosis and treatment of PCa.
Authors
- Jun Mi (ORCID: https://orcid.org/0000-0002-9205-4107)
- Xi Xiao (ORCID: https://orcid.org/0000-0003-1495-4561)
- Liangliang Qing
- Fuxiang Ye (ORCID: https://orcid.org/0000-0003-2550-2173)
- Junqiang Tian (ORCID: https://orcid.org/0000-0002-7064-9636)
- Zonglin Li (ORCID: https://orcid.org/0000-0002-1729-9593)
- Yajia Dong
Institutions
- Lanzhou University Second Hospital (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-09-21
- DOI
- https://doi.org/10.1007/s12672-024-00983-5
- Citations
- 6
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.51